Question · asked by 1 review
Summary of findings table ‐ Methylprednisolone vs placebo: Participant‐reported pain relief of 50% or greater
- Population
- patients with pain in Guillain‐Barré syndrome
- Intervention
- Summary of findings table ‐ Methylprednisolone
- Comparison
- placebo
- Outcome
- Participant‐reported pain relief of 50% or greater
The review found no eligible studies for this question.
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Methylprednisolone vs placebo Number of patients with self reported pain relief of 50% or greater (not measured) · patients with Guillain‐Barré syndrome, with varying severities of pain The review found no eligible studies for this question. Pharmacological treatment for pain in Guillain‐Barré syndrome (2015) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pharmacological treatment for pain in Guillain‐Barré syndrome 2015 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.